Results 251 to 260 of about 3,911,704 (314)

Gut microbiota impact on lung diseases: a mini review of clinical evidence. [PDF]

Infect Immun
Liu C, Dan L, Wang X, Chen L, Yuan X.
europepmc   +1 more source

“Smelltronics”—From Gas to Smell Sensing

Advanced Materials, EarlyView.
The emerging field of smelltronics, encompassing sensing technologies for complex volatile organic compounds, holds significant potential for extracting valuable chemical information. It facilitates the noninvasive, real‐time monitoring of humans, food, and the environment.
Takeshi Ono, Tsunaki Takahashi, Jiangyang Liu, Haruka Honda, Zeng Jing, Wataru Tanaka, Takuro Hosomi, Takeshi Yanagida   +7 more
wiley   +1 more source

e-Lung computed tomography biomarkers are associated with outcomes in fibrotic interstitial lung diseases. [PDF]

ERJ Open Res
Abbasi Dezfouli K, Devaraj A, Ottink FA, Rennison-Jones C, Sifostratoudaki A, Fernandez C, von Stackelberg O, Kauczor HU, Debic M, Schlamp K, Buschulte K, Heussel CP, Briggs JH, Gerry S, Harston GWJ, Bou-Zeid W, Joly O, George PM, Kreuter M.   +18 more
europepmc   +1 more source

Associations between physical activity levels and chronic lung diseases in middle-aged and older adults in China: A CHARLS-based study. [PDF]

PLoS One
Su Z, Pu L, Huang R, Zhu Y, Lin Y, He Y, Mao S, Wang W, Kang W, Liu Y, Liu Y, Lin R, Michael N.   +12 more
europepmc   +1 more source

Pulmonary hypertension associated with nonparenchymal restrictive lung diseases. [PDF]

Eur Respir Rev
Jutant EM, Humbert M, Montani D, Khoury J, Adir Y.   +4 more
europepmc   +1 more source

The clinical relevance of chest computed tomography imaging in pulmonary hypertension associated with lung diseases. [PDF]

Curr Opin Pulm Med
Johnson SW, Rahaghi FN, Estépar RSJ.
europepmc   +1 more source

The relationship between triglyceride-glucose index and chronic lung diseases: a nationwide cohort study. [PDF]

BMC Pulm Med
Li Y, Wu Y, Lei L, Jiang Z, Duan M.
europepmc   +1 more source

Precision Medicine Advances in Chronic Lung Diseases. [PDF]

Int J Mol Sci
Bakakos A, Tzilas V, Loukides S, Bakakos P, Karampitsakos T.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mild parenchymal lung disease is still lung disease

European Respiratory Journal, 2020
Response to correspondence regarding the recent paper: “Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension”https://bit.ly ...
Robin Condliffe, David G. Kiely, Robert A. Lewis   +2 more
openaire   +5 more sources

Rare Lung Diseases: Interstitial Lung Diseases and Lung Manifestations of Rheumatological Diseases

The Indian Journal of Pediatrics, 2015
The concept of Childhood Interstitial Lung Disease (ChILD) is relatively young. There has been tremendous progress in this field in the last decade. The key advance has been the recognition of interstitial lung diseases that are often distinct and occur mainly in infants. Diagnosis is challenging because the incidence is low and no single center in the
Mahesh Babu, Ramamurthy, Daniel Y T, Goh, Michael Teik Chung, Lim   +2 more
openaire   +2 more sources